Advanced Filters
noise

stent Clinical Trials

A listing of stent medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Found 241 clinical trials
S Safa Savadi Osgouei, MD

Complex Abdominal Aortic Aneurysm Repair With Fenestrated Stent Grafts

The purpose of this study is to evaluate clinical outcomes and quality of life measures in treated by endovascular aortic repair of juxtarenal, suprarenal, and type IV thoracoabdominal aortic aneurysms using custom-made Cook Zenith® Fenestrated AAA Endovascular Graft.

18 years of age All Phase N/A
K Kim Laura Suder

Innoventric Trillium™ Stent Graft Early Feasibility Study (EFS)

Early Feasibility Study to evaluate the safety and performance of the Innoventric Trillium™ Stent Graft in the treatment of severe or greater tricuspid regurgitation (TR).

18 - 85 years of age All Phase N/A
G Géraud Souteyrand, Prof.

Optimal Strategy to Correct Stent underexpAnsion in Resistant Lesions

Percutaneous coronary intervention (PCI) for in-stent restenosis (ISR) accounts for 5-10% of PCI. ISR may be linked to mechanical complications mainly under-expansion (UE), neointimal hyperplasia and/or neoatherosclerosis. International guidelines recommends non-compliant and very-high-pressure balloons, which lead to sub-optimal angiographic and clinical results. Recently, observational studies have suggested the feasibility and …

18 years of age All Phase N/A
Y Young Joon Hong, MD, PhD

Late-lumen Changes After Drug-Coated Balloon Angioplasty Versus Drug-Eluting Stents in De Novo Coronary Lesions

This study aims to compare late-lumen loss (LLL) between DCB and DES to treat de novo coronary artery stenosis by intravascular ultrasound (IVUS).

19 years of age All Phase N/A

Study on the Aortic Arch Single Branch Stent Graft System

The objective of the study is to evaluate the Safety and Efficacy of Aortic Arch Single Branch Covered Stent System for Aortic Dissection Involving the Aortic Arch

18 - 80 years of age All Phase N/A
P Philippe De Sousa, MD

Risk Factors for Poor Tolerance of Ureteral Double-J Stent

The placement of a Ureteral Double-J Stent as an emergency treatment or preparation for endoscopy after Colic nephritis is very frequent. It is often poorly supported, most often by young patients. A rich symptomatology is related to the probe responsible for a limitation of activities that can have a strong …

18 years of age All Phase N/A

Influence of Vessel Wall Calcification on Early Stent Strut Healing

To assess the influence of superficial calcium on the early endothelialization (1 month) of the struts of the Xience Skypoint stent (comparing struts with underlying superficial calcium to struts without underlying calcification)

18 years of age All Phase N/A
M Maira MORENO, PHD

Anti-Migration System for Anti-reflux Oeso-gastric Stent (ANTIMIG)

The aim of this prospective, controlled, randomized, multicentre, single-blind study is to compare the rate of intragastric migration of 2 types of esophageal stents with and without an anti-migration device placed for locally advanced or metastatic malignant stenosis of the gastroesophageal junction.

18 - 91 years of age All Phase N/A
J John Ohman

Endovascular Repair With Fenestrated TREO Stent-Graft System in AAA

The goal of this clinical trial is to learn if the Fenestrated TREO Stent-Graft System works to treat abdominal aneurysms in adults. An abdominal aneurysm is a bulge in the main blood vessel (the aorta) which carries blood from the heart, through the chest and abdomen. It will also learn …

18 years of age All Phase N/A
K Karl Mercieca, Prof. Dr.

Comparing XEN®-63 Gel Stent and PRESERFLO® MicroShunt

The goal of this randomized controlled clinical trial is to learn whether two minimally invasive bleb-forming glaucoma implants can effectively treat adult patients with open-angle glaucoma who require surgical lowering of intraocular pressure (IOP). Specifically, the study evaluates whether the PRESERFLO™ MicroShunt is at least as effective as the XEN®-63 …

40 years of age All Phase N/A

Simplify language using AI